Healthcare Industry Joins Forces to Create New Digital Services

Twenty-one leading healthcare organisations have joined a formal partnership to tackle the nation’s healthcare challenges by accelerating growth in the digital healthcare market. Founded and led by D Health, the partnership known as ‘the Catalyst’ involves major brands Celisio (owners of Lloyds Pharmacy) and Johnson and Johnson's LifeScan. Other founding members include SMEs such as Isansys, Grey Matters and Cardio QT and healthcare providers Red House Practice Group, Just Checking and Physiomedics. Amongst others, third sector representatives Highland Hospice and Albyn Housing Society have also signed up alongside supporting organisations corporate financiers Opus, sales business Trocar and a leading consumer psychologist.

Advanced talks with potential members from other UK organisations are currently underway, whilst plans to expand the group into Europe during 2014 have progressed with the addition of Spanish cooperative, TIC Biomed to the group.

The Catalyst is set to meet for the first time in London on 5 February 2014 to discuss how it can provide new, low cost products and services for both consumer and provider markets. These could include innovations such as fitness boosting smart phone apps, blood monitoring devices, TV and phone based services for the elderly and self-management software for diabetics.

Market projections for digital healthcare vary widely, but all point to rapid growth over coming years as demand for services increases. According to a recent report conducted by Frost and Sullivan, the worldwide market for healthcare devices will garner over $509.25 billion in the next 10 years, up 87.5 per cent from $271.55 billion in the current decade.

CEO Dr Steven Dodsworth, formerly a scientist with the UK arm of the Human Genome project, leads D Health. He said: "Everyone in the healthcare industry knows what challenges lie ahead - an ageing population, more lifestyle-related ill health and growing constraints on budgets. In a nutshell, there is an increasing demand for services but fewer resources to deliver them.

"Digital healthcare has the potential to deliver popular, personalised, efficient and affordable patient services, and yet, the market isn’t growing fast enough to alleviate pressure on the NHS and local authorities.

"By creating a partnership that embodies all sections of the healthcare industry we aim to create not only new products and services but a new market dynamic based on collaboration. That way the industry can develop urgently required services that support and supplement sustainable health and care services for the future."

Ken Spooner from the Red House Group of Surgeries added: "The Catalyst offers the opportunity for developers of digital healthcare products to work with those who understand patients' needs, helping them to come up with solutions that can deliver and be part of the NHS healthcare offering in the future."

For further information, please visit:
http://www.dhcl.org

Digital healthcare is a holistic term incorporating telemedicine, telehealth, telecare, E-Health, M-Health, Health IT and Assisted Living. As aging populations, lifestyle related diseases and other social and economic drivers continue to dominate global healthcare systems, digital healthcare is rapidly emerging as a key solution for delivering sustainable health and care for the future.

D Health is a specialist consultancy which provides support services to the global digital healthcare community. Combined, D Health’s core team has over 70 years of experience in healthcare as academics, public servants, industry professionals and business leaders. Calling on its industry experience and networks, D Health’s expertise lies in its ability to identify funding, provide market intelligence, scope opportunities, design business/service models and broker partnerships.

The D Health Catalyst is a market accelerator programme that aims to work with leading organisation from the UK and Europe to drive rapid development of the digital healthcare market. D Health aims to stimulate interaction and development by ensuring the Catalyst represents a full cross-section of the market, from SMEs and blue chip companies to state providers and investors. By achieving this, Catalyst members can work in true collaboration, giving them new insight whilst reducing risk, thereby providing a competitive edge.

Most Popular Now

Most Advanced Artificial Touch for Brain…

For the first time ever, a complex sense of touch for individuals living with spinal cord injuries is a step closer to reality. A new study published in Science, paves...

From Text to Structured Information Secu…

Artificial intelligence (AI) and above all large language models (LLMs), which also form the basis for ChatGPT, are increasingly in demand in hospitals. However, patient data must always be protected...

Deep Learning Model Helps Detect Lung Tu…

A new deep learning model shows promise in detecting and segmenting lung tumors, according to a study published in Radiology, a journal of the Radiological Society of North America (RSNA)...

AI Innovation Unlocks Non-Surgical Way t…

Researchers have developed an artificial intelligence (AI) model to detect the spread of metastatic brain cancer using MRI scans, offering insights into patients’ cancer without aggressive surgery. The proof-of-concept study, co-led...

New Study Reveals AI's Transformati…

Intensive care units (ICUs) face mounting pressure to effectively manage resources while delivering optimal patient care. Groundbreaking research published in the INFORMS journal Information Systems Research highlights how a novel...

One of the Largest Global Surveys of Soc…

As leaders gather for the World Economic Forum Annual Meeting 2025 in Davos, Leaps by Bayer, the impact investing arm of Bayer, and Boston Consulting Group (BCG) announced the launch...

New Computer Models Open Door to Far Mor…

With antibiotic resistance a growing problem, University of Virginia School of Medicine researchers have developed cutting-edge computer models that could give the disease-fighting drugs a laser-like precision to target only...

New Biomarkers to Detect Colorectal Canc…

Machine learning and artificial intelligence (AI) techniques and analysis of large datasets have helped University of Birmingham researchers to discover proteins that have strong predictive potential for colorectal cancer. In a...

Sam Neville Joins the Highland Marketing…

Leading chief nursing information officer Sam Neville is joining the Highland Marketing advisory board. Sam brings a passion for nursing and safety to the board, which debates the big issues...

AI Model Identifies Potential Risk Genes…

Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics models to Parkinson's disease. Researchers identified genetic factors in progression and FDA-approved drugs that can...

AI Tool that may Assist Underserved Hosp…

As the fields of healthcare and technology increasingly evolve and intersect, researchers are collaborating on the best ways to use emerging technologies such as artificial intelligence (AI) to care for...

AI-Supported Breast Cancer Screening - N…

The new findings are published in The Lancet Digital Health. The initial results of the Mammography Screening with Artificial Intelligence (MASAI) study* - a randomised trial to evaluate whether AI...